StockClub

News

Jul 16 (Thu)
MacroInvesco S&P 500 Equal Weight ETFRSPETF Trends

Alternatives ETFs Punching Above Their Weight in 2026

Halfway through the year, the U.S. equity market performance is broadening. That said, market concentration remains incredibly high, while equity and bond correlations sit in positive territory — cond

AnalystHikma Pharmaceuticals PLCHKMPFProactive Investors

Citi starts Hikma at 'buy' with strategy reset offering compelling entry point

Citi has initiated coverage of Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) with a 'buy' rating and a £17 price target, arguing the generic drugmaker's current valuation offers a compelling entry po

ProductSeeking Alpha

Xenon Pharmaceuticals: Azetukalner Has Shifted From Binary Science To Commercial Execution

Xenon Pharmaceuticals (XENE) is transitioning into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform and strong Phase 3 epilepsy data. XENE's lead candidate,

EarningsTesla, Inc.TSLAMarketBeat

Tesla's Delivery Surprise Was Big—Earnings Need to Be Bigger

Tesla TodayTSLATesla$394.35 -1.83 (-0.46%) As of 07/15/2026 04:00 PM Eastern52-Week Range$297.82▼$498.83P/E Ratio361.79Price Target$408.07Add to WatchlistTesla Inc. NASDAQ: TSLA shares have been conso

OtherFirst Solar, Inc.FSLRNewsfile Corp

FSLR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds First Solar (FSLR) Investors of Securities Class Action Lawsuit Deadline on August 24, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In First Solar To Contact Him Directly To Discuss Their Options If you purchased or acqu

EarningsBlackRock, Inc.BLKSeeking Alpha

BlackRock Earnings: Market Dominance, Strong Inflows, And An Extreme Tail Risk

BlackRock, the world's largest asset manager, reported stellar results for the second quarter of 2026 yesterday. In this update, I'll analyze how BlackRock maintains an exceptional 40% operating margi

OtherMicrosoft CorporationMSFTSeeking Alpha

Microsoft: The Inflection Point May Finally Be Here

Microsoft (MSFT) trades at a rare discount, down 30% from its high, despite robust ≈17% EPS growth and sector-wide SaaS weakness. I see the market mispricing MSFT's AI integration; Office 365 remains

Sponsored
EarningsFiskars Oyj AbpFKRAFSeeking Alpha

Fiskars Oyj Abp (FKRAF) Q2 2026 Earnings Call Transcript

Fiskars Oyj Abp (FKRAF) Q2 2026 Earnings Call Transcript

EarningsMips AB (publ)MPZAYSeeking Alpha

Mips AB (publ) (MPZAY) Q2 2026 Earnings Call Transcript

Mips AB (publ) (MPZAY) Q2 2026 Earnings Call Transcript

OtherBitwise XRP ETFXRPFinbold

XRP whales scoop up 70 million tokens in a week

XRP whales – wallets holding at least 1 million tokens – have been on a buying spree over the past seven days, despite a renewed XRP sell-off from United States spot ETFs (exchange-traded funds) issue

OtherASGNewsfile Corp

Aurora Spine and CornerLoc Announce Strategic Commercial Alliance to Expand Minimally Invasive Spine and SI Joint Solutions Nationwide

Carlsbad, California and Tulsa, Oklahoma--(Newsfile Corp. - July 16, 2026) - Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groun

EarningsRKGRYSeeking Alpha

RENK Group AG (RKGRY) Discusses Pre-Close Update and Strong Order Intake Driven by Defense Contracts Prepared Remarks Transcript

RENK Group AG (RKGRY) Discusses Pre-Close Update and Strong Order Intake Driven by Defense Contracts Prepared Remarks Transcript

EarningsSeeking Alpha

Investor AB (publ) (IVSBF) Q2 2026 Earnings Call Transcript

Investor AB (publ) (IVSBF) Q2 2026 Earnings Call Transcript

M&ACNBC

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

Eli Lilly will acquire psychedelic drugmaker AtaiBeckley for $2.8 billion. AtaiBeckley is developing several psychedelics for mental health conditions.

Sponsored
OtherGlobeNewsWire

Brazil Potash Provides Update on Autazes Project Regarding Brazilian Court Filing

MANAUS, Brazil, July 16, 2026 (GLOBE NEWSWIRE) -- Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE-American: GRO), a mineral exploration and development company advancing the Autazes potas

EarningsRaymond James Financial, Inc.RJFSeeking Alpha

Raymond James: Turning Bullish After Earnings Preview And Investor Day (Upgrade)

I raise my rating for Raymond James Financial to a "Buy" after assessing investor event disclosures and previewing its upcoming results release. I expect RJF to beat 3QFY26 EPS consensus, driven by th

EarningsAddLife AB (publ)ADDLFSeeking Alpha

AddLife AB (publ) (ADDLF) Q2 2026 Earnings Call Transcript

AddLife AB (publ) (ADDLF) Q2 2026 Earnings Call Transcript

OtherTeam, Inc.TISIGlobeNewsWire

Bunker Hill Mining Strengthens Executive Team and Achieves Improved ESG Rating in Latest Digbee Assessment

KELLOGG, Idaho and VANCOUVER, British Columbia, July 16, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX: BNKR | OTCQB: BHLL) is pleased to announce that Bradle

AnalystAlaska Air Group, Inc.ALKSeeking Alpha

Alaska Air: The Loss Looks Worse Than The Business

Alaska Air Group is rated Buy with a $60 fair value, reflecting a belief that current losses are driven by temporary fuel shocks. Despite a $193M Q1 loss and suspended guidance, ALK's underlying franc

EarningsUnitedHealth Group IncorporatedUNHForbes

UnitedHealth Group Profits Hit $5.4 Billion As Costs Continue To Ease

UnitedHealth Group Thursday reported second quarter net income of $5.48 billion as medical costs dropped, triggering an improved financial outlook for the rest of the year.